# Safety of NGOIS Compared to BSS Plus in Pediatric Patients

> **NCT00346528** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 18 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Next Generation Ophthalmic Irrigating Solution (NGOIS)
- **DRUG:** BSS Plus

## Key facts

- **NCT ID:** NCT00346528
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346528, "Safety of NGOIS Compared to BSS Plus in Pediatric Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00346528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*